Pharma Marketing Network

By now everyone has heard how the developer of "Flappy Bird" pulled the mobile game from the Apple and Google app stores because it...

Just because a pharma company gets kudos for engaging with and supporting patients via Social Media does not mean the company always has patients'...

Celgene was accused of promoting its cancer drug Thalomid and related compound Revlimid for uses not approved by U.S. regulators in a newly unsealed...

The FDA has just published its "Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2014," which includes...

FDA's "Mini-Sentinel" project released a report on the massive amounts of personally-identifiable health data it is collecting about 160 million patients. According to Alec Gaffney's...

According to Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, developing a strong brand personality is an important way that pharmaceutical marketers can increase brand loyalty, brand trust, and ultimately brand equity.

FDA intends to look for evidence that the 'major statement' of drug risks as currently implemented in DTC TV ads is often too long and 'may result in reduced consumer comprehension, minimization of important risk information and, potentially, therapeutic noncompliance due to fear of side effects.'

Back in June, 2011, Pharmaguy published the first iteration (Volume One) of the Pharmaguy Social Media Timelime™. Since then there have been many noteworthy pharma social media events, trials, and tribulations that deserve to be added to the Timeline. Volume Two includes 23 new items/events from June, 2011 through January, 2014.

Welcome to Volume 13, Issue #2 (February 2014) of Pharma Marketing News.

Now that the FDA has finally published a bit of its long-awaited social media guidelines for the drug industry, I thought it would be...